Phathom Pharmaceuticals Q4 2025 Earnings Preview
Source: SeekingAlpha
2026-02-25 12:25:32 ET
More on Phathom Pharmaceuticals
- Phathom: Why I'm Not Buying The Dip (Yet)
- Phathom slumps 12%; prices $130M stock at $16 per share
- Phathom Pharma plans public offering after reporting preliminary 2025 results
- Seeking Alpha’s Quant Rating on Phathom Pharmaceuticals
- Historical earnings data for Phathom Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Phathom Pharmaceuticals Q4 2025 Earnings Preview
Phathom Pharmaceuticals Inc.
NASDAQ: PHAT
PHAT Trading
6.29% G/L:
$10.98 Last:
220,744 Volume:
$10.50 Open:
PHAT Latest News
February 26, 2026 07:00:00 am
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
PHAT Stock Data
$1,007,653,754
60,286,977
0.48%
62
N/A
Biotechnology & Life Sciences
Healthcare
US
Florham Park
